108 related articles for article (PubMed ID: 1341239)
1. Effects of cyclosporine on human B-cell lymphoma development in vivo.
Boyle TJ; Coles RE; Kizilbash AM; Lyerly HK
Surg Oncol; 1992 Feb; 1(1):79-86. PubMed ID: 1341239
[TBL] [Abstract][Full Text] [Related]
2. Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus.
Boyle TJ; Tamburini M; Berend KR; Kizilbash AM; Borowitz MJ; Lyerly HK
Surgery; 1992 Aug; 112(2):378-86. PubMed ID: 1322566
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse.
Gan R; Yin Z; Liu T; Wang L; Tang Y; Song Y
Cancer Sci; 2003 Sep; 94(9):796-801. PubMed ID: 12967478
[TBL] [Abstract][Full Text] [Related]
4. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK
Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.
Mosier DE; Picchio GR; Baird SM; Kobayashi R; Kipps TJ
Cancer Res; 1992 Oct; 52(19 Suppl):5552s-5553s. PubMed ID: 1327510
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus serology and isoelectrofocusing pattern of serum immunoglobulins in cyclosporin or placebo-treated type I diabetics.
Feutren G; de The G; Bach JF
J Autoimmun; 1992 Apr; 5(2):161-72. PubMed ID: 1320887
[TBL] [Abstract][Full Text] [Related]
7. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
Tanner JE; Alfieri C
Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
[TBL] [Abstract][Full Text] [Related]
8. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.
Baiocchi RA; Caligiuri MA
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5577-81. PubMed ID: 7911241
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
Picchio GR; Kobayashi R; Kirven M; Baird SM; Kipps TJ; Mosier DE
Cancer Res; 1992 May; 52(9):2468-77. PubMed ID: 1314693
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines.
Beatty PR; Krams SM; Esquivel CO; Martinez OM
Transplantation; 1998 May; 65(9):1248-55. PubMed ID: 9603175
[TBL] [Abstract][Full Text] [Related]
11. Construction of hu-PBL/SCID chimeras and development of EBV-related lymphomas.
Gan RL; Lan K; Yin ZH; Wang LJ; Song Y; Yao KT
Chin Med Sci J; 2005 Mar; 20(1):16-22. PubMed ID: 15844306
[TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma.
Boyle TJ; Berend KR; DiMaio JM; Coles RE; Via DF; Lyerly HK
Surgery; 1993 Aug; 114(2):218-25; discussion 226. PubMed ID: 8393595
[TBL] [Abstract][Full Text] [Related]
13. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
[TBL] [Abstract][Full Text] [Related]
14. Preventive effect of IgG from EBV-seropositive donors on the development of human lympho-proliferative disease in SCID mice.
Abedi MR; Linde A; Christensson B; Mackett M; Hammarström L; Smith CI
Int J Cancer; 1997 May; 71(4):624-9. PubMed ID: 9178818
[TBL] [Abstract][Full Text] [Related]
15. Human immunoglobulin preparations suppress the occurrence of Epstein-Barr virus-associated lymphoproliferation.
Nadal D; Guzman J; Fröhlich S; Braun DG
Exp Hematol; 1997 Mar; 25(3):223-31. PubMed ID: 9091298
[TBL] [Abstract][Full Text] [Related]
16. Human-->mouse radiation chimera do not develop Epstein-Barr virus lymphoma.
Marcus H; Burakova T; Shezen E; David M; Canaan A; Lubin I; Reisner Y
Immunol Lett; 1996 Mar; 49(3):155-61. PubMed ID: 8739310
[TBL] [Abstract][Full Text] [Related]
17. EBV-induced human B cell lymphomas in hu-PBL-SCID mice.
Mosier DE; Picchio GR; Kirven MB; Garnier JL; Torbett BE; Baird SM; Kobayashi R; Kipps TJ
AIDS Res Hum Retroviruses; 1992 May; 8(5):735-40. PubMed ID: 1325170
[TBL] [Abstract][Full Text] [Related]
18. The use of an anti-CD3 immunotoxin to prevent the development of lymphoproliferative disease in SCID/PBL mice.
Clinchy B; Vitetta ES
J Immunol Methods; 1998 Sep; 218(1-2):141-53. PubMed ID: 9819131
[TBL] [Abstract][Full Text] [Related]
19. Lymphoproliferative disease in SCID mice reconstituted with human Sjögren's syndrome lymphocytes.
Fox RI; Pisa P; Pisa EK; Kang HI
J Clin Lab Anal; 1993; 7(1):46-56. PubMed ID: 8381174
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus DNA in serum after liver transplantation--surveillance of viral activity during treatment with different immunosuppressive agents.
Barkholt LM; Dahl H; Enbom M; Lindé A
Transpl Int; 1996; 9(5):439-45. PubMed ID: 8875785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]